Pain Management — Medicare Part B billing by state
114 physician groups whose primary specialty is Pain Management billed $0.05B to Medicare fee-for-service in 2024.
Calendar year 2024 · Medicare fee-for-service Part B
| State | Groups | Services | Beneficiary-episodes | Medicare payments | Standardized payments ↓ | Payments / group | Services / group |
|---|---|---|---|---|---|---|---|
| Florida | 13 | 351,535 | 64,496 | $10,726,561 | $10,778,850 | $825,120 | 27,041 |
| California | 18 | 252,175 | 35,481 | $7,664,724 | $7,242,101 | $425,818 | 14,010 |
| Texas | 12 | 191,875 | 29,931 | $4,898,971 | $5,075,093 | $408,248 | 15,990 |
| Georgia | 5 | 55,699 | 25,482 | $3,857,141 | $3,956,513 | $771,428 | 11,140 |
| New Jersey | 8 | 78,624 | 18,950 | $3,904,877 | $3,811,005 | $488,110 | 9,828 |
| Pennsylvania | 11 | 105,477 | 24,640 | $3,692,511 | $3,696,672 | $335,683 | 9,589 |
| Delaware | 3 | 130,937 | 25,040 | $3,316,938 | $3,436,056 | $1,105,646 | 43,646 |
| Illinois | 6 | 149,035 | 20,234 | $2,654,157 | $2,620,908 | $442,359 | 24,839 |
| Arizona | 4 | 35,264 | 13,804 | $2,151,970 | $2,214,909 | $537,993 | 8,816 |
| Oklahoma | 2 | 32,735 | 14,091 | $1,975,032 | $2,144,368 | $987,516 | 16,368 |
| New York | 10 | 99,725 | 10,628 | $1,978,530 | $1,841,764 | $197,853 | 9,972 |
| Virginia | 4 | 19,499 | 7,550 | $950,756 | $1,012,132 | $237,689 | 4,875 |
| Arkansas | 2 | 9,733 | 6,305 | $795,575 | $885,407 | $397,788 | 4,866 |
| Louisiana | 3 | 13,922 | 5,635 | $738,530 | $809,021 | $246,177 | 4,641 |
| Nevada | 3 | 11,679 | 4,718 | $699,170 | $720,397 | $233,057 | 3,893 |
| Ohio | 3 | 13,903 | 3,227 | $683,320 | $686,470 | $227,773 | 4,634 |
| Kentucky | 3 | 11,732 | 3,160 | $526,119 | $563,069 | $175,373 | 3,911 |
| Kansas | 2 | 9,565 | 3,443 | $468,600 | $514,984 | $234,300 | 4,782 |
| Massachusetts | 2 | 23,234 | 2,434 | $442,265 | $460,326 | $221,133 | 11,617 |
| Utah | 1 | 8,490 | 2,169 | $387,925 | $406,441 | $387,925 | 8,490 |
| Alabama | 3 | 7,250 | 2,365 | $301,448 | $325,400 | $100,483 | 2,417 |
| New Mexico | 2 | 6,433 | 2,242 | $256,058 | $272,366 | $128,029 | 3,216 |
| North Carolina | 3 | 2,714 | 1,679 | $240,430 | $239,952 | $80,143 | 905 |
| Wisconsin | 1 | 3,355 | 2,107 | $201,083 | $214,058 | $201,083 | 3,355 |
| Michigan | 4 | 4,836 | 1,388 | $202,094 | $199,024 | $50,524 | 1,209 |
| Oregon | 2 | 2,748 | 1,177 | $166,044 | $164,332 | $83,022 | 1,374 |
| North Dakota | 1 | 1,355 | 944 | $60,401 | $62,210 | $60,401 | 1,355 |
| PR | 2 | 552 | 368 | $60,110 | $60,004 | $30,055 | 276 |
| Tennessee | 1 | 566 | 207 | $28,919 | $29,758 | $28,919 | 566 |
| Indiana | 1 | 246 | 212 | $22,320 | $23,637 | $22,320 | 246 |
| Maryland | 1 | 753 | 177 | $22,111 | $22,059 | $22,111 | 753 |
| Vermont | 1 | 170 | 113 | $8,648 | $8,714 | $8,648 | 170 |
| Colorado | 1 | 134 | 72 | $7,423 | $8,109 | $7,423 | 134 |
Need this specialty's market in one document?
Notify me at launchEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2024
| Code | Services | Medicare payments ↓ | Largest state markets |
|---|---|---|---|
| 99214 · Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 159,134 | $14,383,010 | FLCATXGANJ |
| 99213 · Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 84,015 | $5,328,203 | FLCATXGANJ |
| 80307 · Testing for presence of drug, by chemistry analyzers | 37,363 | $2,240,068 | FLCATXGANJ |
| 64635 · Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | 6,284 | $2,035,950 | FLCATXGANJ |
| G0482 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 10,118 | $1,958,885 | FLCATXGANJ |
| 64483 · Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 11,177 | $1,917,650 | FLCATXGANJ |
| G0481 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 11,230 | $1,705,561 | FLCATXGANJ |
| 62323 · Injection of substance into lower spine canal using imaging guidance | 10,548 | $1,653,298 | FLCATXGANJ |
| 99204 · New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 13,609 | $1,650,942 | FLCATXGANJ |
| G0483 · Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 6,663 | $1,583,802 | FLCATXGANJ |
| 96127 · Assessment of emotional or behavioral problems top by services | 50,171 | $157,648 | FLCATXGANJ |
| J3301 · Injection, triamcinolone acetonide, not otherwise specified, 10 mg top by services | 79,686 | $61,087 | FLCATXGANJ |
| J1010 · Injection, methylprednisolone acetate, 1 mg top by services | 418,413 | $42,121 | FLCATXGANJ |
| J1439 · Injection, ferric carboxymaltose, 1 mg top by services | 39,750 | $34,747 | FLCATXGANJ |
| Q9966 · Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml top by services | 65,782 | $19,074 | FLCATXGANJ |
| J1100 · Injection, dexamethasone sodium phosphate, 1 mg top by services | 113,767 | $10,060 | FLCATXGANJ |
| Q9967 · Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml top by services | 43,517 | $4,499 | FLCATXGANJ |
Every code above is searchable free at full depth. Ranking organizations across several codes at once — one combined market view — is part of a Nevvi subscription.
Notify me at launch